New Data At ESC Congress 2021 Shows Repatha® Improves Features Of Plaque Stability In Patients With Acute Coronary Syndrome Biotech Investing
Awakn Life Sciences CEO Anthony Tennyson: Developing and Delivering the Next Generation of Addiction Treatments Video Interview
NATERA Plant-Based Products to Launch at Denny’s Restaurants across Canada Following Menu Test in B.C. Biotech Investing
AbbVie Receives a Positive Reimbursement Recommendation from the Canadian Agencies for Drugs and Technology in Health pan-Canadian Oncology Drug Review Expert Review Committee for VENCLEXTA® in Combination with azacitidine for Acute Myeloid Leukemia Patients Biotech Investing
NATERA Plant-Based Products to Launch at Denny's Restaurants across Canada Following Menu Test in B.C. Biotech Investing
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Trillium Therapeutics Inc. Biotech Investing
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Trillium Therapeutics, Inc. Buyout Biotech Investing
TRILLIUM ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of TRIL and Encourages Investors to Contact the Firm Biotech Investing
European Commission Approves RINVOQ® as First JAK Inhibitor in the European Union for the Treatment of Both Adults and Adolescents with Moderate to Severe Atopic Dermatitis Biotech Investing
